These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36865465)

  • 41. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dipeptidyl peptidase IV inhibition of phytocompounds from
    Supandi S; Wulandari MS; Samsul E; Azminah A; Purwoko RY; Herman H; Kuncoro H; Ibrahim A; Silfi Ambarwati NS; Rosmalena R; Azizah RN; Paramita S; Ahmad I
    J Adv Pharm Technol Res; 2022; 13(3):207-215. PubMed ID: 35935696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D-QSAR, docking and molecular dynamics simulations of novel Pyrazolo-pyridazinone derivatives as covalent inhibitors of FGFR1: a scientific approach for possible anticancer agents.
    Hamza S; Abid A; Khanum A; Chohan TA; Saleem H; Maqbool Khan K; Khurshid U; Butt J; Anwar S; Alafnan A; Ansari SA; Qayyum A; Raza A; Chohan TA
    J Biomol Struct Dyn; 2024 Mar; 42(5):2242-2256. PubMed ID: 37211823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Finding a Novel Chalcone-Cinnamic Acid Chimeric Compound with Antiproliferative Activity against MCF-7 Cell Line Using a Free-Wilson Type Approach.
    Ventura-Salazar IAY; Palacios-Can FJ; González-Maya L; Sánchez-Carranza JN; Antunez-Mojica M; Razo-Hernández RS; Alvarez L
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513358
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate.
    Edache EI; Uzairu A; Mamza PA; Shallangwa GA
    J Genet Eng Biotechnol; 2022 Dec; 20():88. PubMed ID: 35730025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
    Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
    Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories.
    Ash J; Fourches D
    J Chem Inf Model; 2017 Jun; 57(6):1286-1299. PubMed ID: 28471171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
    Gupta A; Kumar V; Aparoy P
    Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
    Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
    J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P; Bari S
    Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational investigation reveals Picrasidine C as selective PPARα lead: binding pattern, selectivity mechanism and ADME/tox profile.
    Li F; Wang H; Wang Y; Feng S; Hu B; Zhang X; Wang J; Li W; Cheng M
    J Biomol Struct Dyn; 2020 Nov; 38(18):5401-5418. PubMed ID: 31787028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies.
    Abchir O; Daoui O; Belaidi S; Ouassaf M; Qais FA; ElKhattabi S; Belaaouad S; Chtita S
    J Mol Model; 2022 Mar; 28(4):106. PubMed ID: 35352175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular docking, 3D-QSAR, and molecular dynamics simulations of thieno[3,2-b]pyrrole derivatives against anticancer targets of KDM1A/LSD1.
    Zhang X; Yan J; Wang H; Wang Y; Wang J; Zhao D
    J Biomol Struct Dyn; 2021 Mar; 39(4):1189-1202. PubMed ID: 32036765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-guided Design and Optimization of small Molecules as Pancreatic Lipase Inhibitors using Pharmacophore, 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation Studies.
    Modanwal S; Mulpuru V; Mishra N
    Curr Comput Aided Drug Des; 2023; 19(4):258-277. PubMed ID: 36597611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration of
    Zhao Y; Yang H; Wu F; Luo X; Sun Q; Feng W; Ju X; Liu G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
    Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theoretical studies on the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib and its derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation.
    Zhu J; Ke K; Xu L; Jin J
    J Mol Model; 2019 Jul; 25(8):242. PubMed ID: 31338599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virtual screening of PEBP1 inhibitors by combining 2D/3D-QSAR analysis, hologram QSAR, homology modeling, molecular docking analysis, and molecular dynamic simulations.
    Stitou M; Toufik H; Akabli T; Lamchouri F
    J Mol Model; 2022 May; 28(6):145. PubMed ID: 35545728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.